Abbott Labs Sells Developed Markets Generics Unit

July 14 (Bloomberg) -- Marshall Sonenshine, chairman and managing partner at Sonenshine Partners, and Jonathan Golub, chief U.S. market strategist at RBC Capital Markets, examine Abbott Laboratories selling its developed markets generic drug unit to Mylan in a deal worth $5.3 Billion and what it means to the current M&A market. They speak on “Bloomberg Surveillance.”

Sales Check With Hudson's Bay CEO Jerry Storch
56:49 - Hudson's Bay CEO Jerry Storch weighs in on Black Friday sales. He speaks on "Bloomberg Markets." (Source: Bloomberg)
  • Black Friday Retail Sales: The Winners & the Losers
  • Battle of the Charts: Retail Traffic, Euro Versus Dollar
  • 2016 Will Be a Better Year for Stocks, Here's Why